Matches in Wikidata for { <http://www.wikidata.org/entity/Q85015607> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q85015607 description "artículu científicu espublizáu en setiembre de 2012" @default.
- Q85015607 description "scientific article published on 19 September 2012" @default.
- Q85015607 description "wetenschappelijk artikel" @default.
- Q85015607 description "наукова стаття, опублікована у вересні 2012" @default.
- Q85015607 description "գիտական հոդված հրատարակված 2012 թվականի սեպտեմբերի 19-ին" @default.
- Q85015607 name "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)" @default.
- Q85015607 name "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)" @default.
- Q85015607 type Item @default.
- Q85015607 label "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)" @default.
- Q85015607 label "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)" @default.
- Q85015607 prefLabel "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)" @default.
- Q85015607 prefLabel "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)" @default.
- Q85015607 P1433 Q85015607-E13FBE75-A148-4D47-9028-26789DC057AF @default.
- Q85015607 P1476 Q85015607-C267C3B7-3D7F-43E6-9686-F71D57B4B43C @default.
- Q85015607 P2093 Q85015607-1F552B40-A35A-4105-AA40-C4D37838F020 @default.
- Q85015607 P2093 Q85015607-70031FDE-B83E-4239-BC1F-073410EDC3E1 @default.
- Q85015607 P2093 Q85015607-BF5D4EEA-57F4-43AD-A612-BC00B3C8E4DE @default.
- Q85015607 P2093 Q85015607-EE617AAE-5BDF-483A-B7ED-BF4EC4B2B154 @default.
- Q85015607 P304 Q85015607-4C59A01E-80C6-4659-B6D0-21B9ACCD4DDD @default.
- Q85015607 P31 Q85015607-7F7DA205-A0C7-411B-A560-163B65106A00 @default.
- Q85015607 P356 Q85015607-777AC0FB-BE16-4821-9DFC-6118BC3AFF13 @default.
- Q85015607 P433 Q85015607-7433BD1F-3DD3-4396-837A-DEC297549CE1 @default.
- Q85015607 P478 Q85015607-7617A8D7-748A-47B4-80C0-FEC5D1D2618E @default.
- Q85015607 P50 Q85015607-37488CC1-5622-4AA7-9FCC-4411B533AD21 @default.
- Q85015607 P50 Q85015607-5B475B7D-E24A-4365-9D59-35C97DF64311 @default.
- Q85015607 P50 Q85015607-6EBE8D4B-72E9-4295-95CE-32C9E707ADF7 @default.
- Q85015607 P50 Q85015607-7D95DAB3-9C0D-4FE0-AA6C-BC15704D6CAE @default.
- Q85015607 P50 Q85015607-893FBE2D-E288-4818-A771-E85FECFE6A1A @default.
- Q85015607 P50 Q85015607-9A2A48FC-D533-431D-A899-34F9EEAD97EE @default.
- Q85015607 P50 Q85015607-9EB8212B-8672-4D9C-9972-BAB9F67559D0 @default.
- Q85015607 P50 Q85015607-A998D946-F72E-4FC1-9073-593D87E0EF89 @default.
- Q85015607 P50 Q85015607-AB12C0DF-37B7-44B6-B365-FB388AC24CED @default.
- Q85015607 P50 Q85015607-ABA28ACC-8C08-45C4-9021-507E8E97A2C1 @default.
- Q85015607 P50 Q85015607-AF9B28BE-F52A-4D95-A963-DF5C493B2DE7 @default.
- Q85015607 P50 Q85015607-D7F9804F-51CD-4690-AE04-527A70ABCC5C @default.
- Q85015607 P577 Q85015607-B6F87707-8BB6-44FA-A687-B2186D912AB3 @default.
- Q85015607 P698 Q85015607-137338CA-833D-4A7C-8697-6877CB9EC1D7 @default.
- Q85015607 P356 J.JACC.2012.06.043 @default.
- Q85015607 P698 22999717 @default.
- Q85015607 P1433 Q2984355 @default.
- Q85015607 P1476 "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)" @default.
- Q85015607 P2093 "Bum-Kee Hong" @default.
- Q85015607 P2093 "Jung-Han Yoon" @default.
- Q85015607 P2093 "Jung-Sun Kim" @default.
- Q85015607 P2093 "Seung-Hwan Lee" @default.
- Q85015607 P304 "1340-1348" @default.
- Q85015607 P31 Q13442814 @default.
- Q85015607 P356 "10.1016/J.JACC.2012.06.043" @default.
- Q85015607 P433 "15" @default.
- Q85015607 P478 "60" @default.
- Q85015607 P50 Q114435935 @default.
- Q85015607 P50 Q114435940 @default.
- Q85015607 P50 Q59566044 @default.
- Q85015607 P50 Q59679916 @default.
- Q85015607 P50 Q59695831 @default.
- Q85015607 P50 Q60327489 @default.
- Q85015607 P50 Q60571935 @default.
- Q85015607 P50 Q64147216 @default.
- Q85015607 P50 Q73843095 @default.
- Q85015607 P50 Q82184963 @default.
- Q85015607 P50 Q88740977 @default.
- Q85015607 P50 Q90731730 @default.
- Q85015607 P577 "2012-09-19T00:00:00Z" @default.
- Q85015607 P698 "22999717" @default.